JUBLINGREASpecialty Chemicals
Jubilant Ingrevia Ltd — Profit & Loss Statement
₹543.70
-4.50%
Jubilant Ingrevia Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Reconciled Depreciation | 157.63 Cr | 136.17 Cr | 122.18 Cr | 123.39 Cr | — |
| Reconciled Cost Of Revenue | 2.11K Cr | 2.14K Cr | 2.70K Cr | 2.96K Cr | — |
| EBITDA | 556.88 Cr | 456.44 Cr | 579.29 Cr | 859.42 Cr | — |
| EBIT | 399.25 Cr | 320.27 Cr | 457.11 Cr | 736.03 Cr | — |
| Net Interest Income | -55.64 Cr | -52.66 Cr | -20.34 Cr | -29.74 Cr | — |
| Interest Expense | 55.64 Cr | 52.66 Cr | 20.39 Cr | 27.09 Cr | — |
| Normalized Income | 251.17 Cr | 182.89 Cr | 308.50 Cr | 483.08 Cr | — |
| Net Income From Continuing And Discontinued Operation | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Total Expenses | 3.76K Cr | 3.82K Cr | 4.30K Cr | 4.18K Cr | — |
| Diluted Average Shares | 15.86 Cr | 15.83 Cr | 15.90 Cr | 15.90 Cr | — |
| Basic Average Shares | 15.81 Cr | 15.82 Cr | 15.90 Cr | 15.90 Cr | — |
| Diluted EPS | 15.84 | 11.55 | 19.33 | 29.97 | — |
| Basic EPS | 15.89 | 11.56 | 19.34 | 29.98 | — |
| Diluted NI Availto Com Stockholders | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Net Income Common Stockholders | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Including Noncontrolling Interests | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Net Income Continuous Operations | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Tax Provision | 92.44 Cr | 84.72 Cr | 129.22 Cr | 232.23 Cr | — |
| Pretax Income | 343.61 Cr | 267.61 Cr | 436.71 Cr | 708.94 Cr | — |
| Other Non Operating Income Expenses | 37.82 Cr | 35.30 Cr | 32.04 Cr | 30.30 Cr | — |
| Net Non Operating Interest Income Expense | -55.64 Cr | -52.66 Cr | -20.34 Cr | -29.74 Cr | — |
| Interest Expense Non Operating | 55.64 Cr | 52.66 Cr | 20.39 Cr | 27.09 Cr | — |
| Operating Income | 361.45 Cr | 284.95 Cr | 444.10 Cr | 734.09 Cr | — |
| Operating Expense | 1.65K Cr | 1.67K Cr | 1.60K Cr | 1.22K Cr | — |
| Other Operating Expenses | 1.13K Cr | 1.19K Cr | 1.10K Cr | 749.12 Cr | — |
| Depreciation And Amortization In Income Statement | 157.63 Cr | 136.17 Cr | 122.18 Cr | 123.39 Cr | — |
| Depreciation Income Statement | 157.63 Cr | 136.17 Cr | 119.18 Cr | 121.54 Cr | — |
| Gross Profit | 2.02K Cr | 1.96K Cr | 2.04K Cr | 1.96K Cr | — |
| Cost Of Revenue | 2.11K Cr | 2.14K Cr | 2.70K Cr | 2.96K Cr | — |
| Total Revenue | 4.12K Cr | 4.10K Cr | 4.74K Cr | 4.91K Cr | — |
| Operating Revenue | 4.12K Cr | 4.10K Cr | 4.74K Cr | 4.91K Cr | — |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.42 Cr | -3.10 Cr | — |
| Tax Rate For Calcs | 0.27 | 0.32 | 0.30 | 0.33 | — |
| Normalized EBITDA | 556.88 Cr | 456.44 Cr | 580.71 Cr | 868.90 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 251.17 Cr | 182.89 Cr | 307.50 Cr | 476.71 Cr | — |
| Interest Income | — | 1.01 Cr | 1.24 Cr | 1.20 Cr | 0.56 Cr |
| Rent Expense Supplemental | — | 3.09 Cr | 1.99 Cr | 1.61 Cr | 0.48 Cr |
| Special Income Charges | — | -6.35 Cr | -1.42 Cr | -9.48 Cr | -12.94 Cr |
| Other Special Charges | — | 6.35 Cr | 1.42 Cr | 9.48 Cr | 12.94 Cr |
| Total Other Finance Cost | — | 0.65 Cr | 1.18 Cr | 3.84 Cr | 0.35 Cr |
| Interest Income Non Operating | — | 1.01 Cr | 1.24 Cr | 1.20 Cr | 0.56 Cr |
| Amortization | — | 3.14 Cr | 3.01 Cr | 1.85 Cr | 0.34 Cr |
| Selling General And Administration | — | 91.40 Cr | 56.45 Cr | 51.60 Cr | 6.56 Cr |
| Selling And Marketing Expense | — | 10.60 Cr | 11.61 Cr | 5.78 Cr | 0.18 Cr |
| General And Administrative Expense | — | 80.80 Cr | 44.84 Cr | 45.82 Cr | 6.38 Cr |
| Rent And Landing Fees | — | 3.09 Cr | 1.99 Cr | 1.61 Cr | 0.48 Cr |
| Total Unusual Items | — | -6.35 Cr | -1.42 Cr | -9.48 Cr | -12.94 Cr |
| Total Unusual Items Excluding Goodwill | — | -6.35 Cr | -1.42 Cr | -9.48 Cr | -12.94 Cr |
| Impairment Of Capital Assets | — | — | — | 0.00 | 12.94 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Jubilant Ingrevia Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.